Vertex Pharmaceuticals (Europe) Limited
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Phone call (2-5)
Calls with TDs and Senators concerned with negotiations on the drug Orkambi, regarding the HSE's Reimbursement Process
Meeting (11-20)
Meetings with TDs and Senators concerned with negotiations on the drug Orkambi, regarding the HSE's Reimbursement Process
Email (11-20)
Emailed TDs and Senators concerned with negotiations on the drug Orkambi, regarding the HSE's Reimbursement Process
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.